Averto Medical

Executive Summary

Averto Medical is a privately held, clinical-stage medical technology company headquartered in Austin, Texas, founded in 2018. The company is dedicated to improving outcomes for patients with gastrointestinal diseases, with an initial focus on colorectal surgery. Its core technology aims to protect anastomoses—the surgical connections made after bowel resection—which are prone to leakage and complications. By developing a novel device or approach to reinforce these connections, Averto seeks to reduce postoperative morbidity, shorten hospital stays, and lower healthcare costs. The company's mission addresses a significant unmet need, as anastomotic leaks occur in 3–20% of colorectal procedures and remain a leading cause of mortality and reoperation.

Upcoming Catalysts (preview)

• Q4 2026Completion of First-in-Human Study Enrollment70% success
• Q1 2027Initial Safety and Efficacy Data from Phase 1 Trial60% success
• Q2 2027FDA Investigational Device Exemption (IDE) Approval for Pivotal Trial50% success